We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
DELISTED
Trinseo
TSE
| – | – |
-6
| Closed | – | – |
|
3277
Taysha Gene Therapies
TSHA
$1.22B
| – | – |
-45
| Closed | -$1K | – |
|
3278
DELISTED
2seventy bio
TSVT
| $0 | ﹤0.01% |
+14
| New | +$237 |
2022 Q1
0 quarters
|
|
3279
DELISTED
Tile Shop Holdings
TTSH
| – | – |
-5
| Closed | – | – |
|
3280
Uranium Energy
UEC
$4.05B
| – | – |
-91
| Closed | – | – |
|
3281
Universal Electronics
UEIC
$66.6M
| – | – |
-7
| Closed | – | – |
|
3282
Unisys
UIS
$164M
| $0 | ﹤0.01% |
+7
| New | +$142 |
2022 Q1
0 quarters
|
|
3283
United Natural Foods
UNFI
$2.91B
| – | – |
-175
| Closed | -$9K | – |
|
3284
Upbound Group
UPBD
$959M
| – | – |
-188
| Closed | -$9K | – |
|
3285
Upland Software
UPLD
$8.31M
| $0 | ﹤0.01% |
1
-21
| -95% | -$3.85K |
2021 Q2
3 quarters
|
|
3286
Americas Gold and Silver
USAS
$1.31B
| $0 | ﹤0.01% |
+52
| New | +$124 |
2022 Q1
0 quarters
|
|
3287
Utah Medical Products
UTMD
$238M
| – | – |
-83
| Closed | -$7.63K | – |
|
3288
Veracyte
VCYT
$3.57B
| – | – |
-4
| Closed | – | – |
|
3289
Vir Biotechnology
VIR
$1.77B
| $0 | ﹤0.01% |
10
-44
| -81% | -$1.3K |
2020 Q2
7 quarters
|
|
3290
Vital Farms
VITL
$367M
| $0 | ﹤0.01% |
20
-16
| -44% | -$240 |
2021 Q2
3 quarters
|
|
3291
Vanda Pharmaceuticals
VNDA
$256M
| – | – |
-46
| Closed | -$1K | – |
|
3292
Vor Biopharma
VOR
$1.14B
| – | – |
-25
| Closed | -$6K | – |
|
3293
Vishay Precision Group
VPG
$853M
| $0 | ﹤0.01% |
7
+5
| +250% | +$162 |
2016 Q4
21 quarters
|
|
3294
Vroom Inc
VRM
$46.3M
| – | – |
0
| – | – |
2021 Q2
3 quarters
|
|
3295
V2X
VVX
$2.15B
| – | – |
-59
| Closed | -$3K | – |
|
3296
Vanguard International High Dividend Yield ETF
VYMI
$21.5B
| – | – |
-500
| Closed | -$34K | – |
|
3297
Energous
WATT
$49.5M
| – | – |
0
| – | – |
2021 Q2
3 quarters
|
|
3298
West Fraser Timber
WFG
$5.13B
| $0 | ﹤0.01% |
2
| – | – |
2021 Q3
2 quarters
|
|
3299
Cactus
WHD
$4.27B
| – | – |
-58
| Closed | -$2K | – |
|
3300
Wingstop
WING
$3.57B
| $0 | ﹤0.01% |
3
+2
| +200% | +$284 |
2021 Q4
1 quarter
|
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.